◆ 会议时间：2023年9月20日至23日
◆ 会议地点：意大利 米兰
◆ 会议简介：
2023年第7届CRI-ENCI-AACR国际癌症免疫治疗大会将于2023年9月20日至23日在意大利米兰举行，会议议题涵盖癌症免疫学和免疫治疗的所有研究领域。该会议于2015年启动，由癌症研究所（CRI）、欧洲癌症免疫治疗网络(ENCI)和美国癌症研究协会（AACR）联合主办。会议每年举行一次，在美国和欧洲之间轮流举行。通过这种合作，这些组织旨在更有效地传播癌症免疫学和免疫治疗方面最前沿的信息和研究，并为该领域宣所有利益相关者提供交流、学习和沟通的机会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）
CICON 2023
Seventh
CRI-ENCI-AACR International Cancer Immunotherapy Conference 2023
Translating Science into Survival
Dates: September 20-23, 2023
Venue: Milan, Italy
Organized by:
Cancer Research Institute (CRI)
European Network for Cancer Immunotherapy (ENCI)
American Association for Cancer Research (AACR)
摘要征文投稿：
Important Dates
Abstract Submission Deadline: June 15, 2023
Abstract Status Notification Date: July 17, 2023
Advance Registration Deadline: June 26, 2023
Withdrawal Deadline: July 15, 2023
SUBMIT YOUR ABSTRACT
Notification of Abstract Status
All individuals listed as Submitting Authors will be notified of acceptance or rejection by email to the address provided for the abstract submitter at the time of submission.
Presentation and Publication
The titles and presenting authors of all regular abstracts scheduled for presentation at this conference will be available online prior to the conference. With the exception of abstracts selected for a conference press program (if applicable), all conference abstracts will not be available untilfew days before the meeting will start.
Poster boards dimensions will be provided in email correspondence to the Submitting Authors. The organizers will provide poster numbers and pushpins.
From the accepted posters, a small number of highly rated abstract authors will also be invited to deliver short oral proffered presentations of their work during the general sessions. All abstracts will be considered. Instructions will be sent to the Submitting Authors with the date, time, and format for these presentations.
Conference Registration
Presenting Authors must register for the conference prior to the submission of an abstract and attend the session in which the abstract is scheduled. If an abstract is not accepted, the presenter may request a full refund of the registration fee.
Request for Withdrawal
Once an abstract has been submitted, it may be withdrawn only by written request from the Submitting Author. The request may be sent by email to abstracts@cancerimmunotherapyconference.org and must be received by July 15.
If due to unforeseen circumstances the designated Presenting Author is unavailable to attend the session to present the abstract, the Submitting Author must contact abstracts@cancerimmunotherapyconference.org to designate a co-author to serve as the Presenting Author. If no authors are available to present the abstract, the Submitting Author must withdraw the abstract immediately by emailing abstracts@cancerimmunotherapyconference.org.
Submission
Abstract may only be submitted through the online abstract submission platform. Only those abstracts that have been reviewed and selected by the Scientific Planning Committee may be presented. Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The organizers do not proofread or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted. For technical questions or if you have policy related questions, please contact the abstract submission help desk at abstracts@cancerimmunotherapyconference.org.
Abstract Categories
- With a little help from my friends: innate immune cells and stromal cells in the tumor microenvironment
-
Deranged T and B cells within the tumor microenvironment
-
Lung cancer at the forefront of cancer immunotherapy
-
Harnessing immunotherapy against breast cancer
-
The earlier the better: neoadjuvant immunotherapy against cancer
-
Technologies, technologies, technologies: we need more
-
How to overcome resistance of poorly sensitive tumors to immunotherapy
-
What’s next in the pipeline of melanoma treatment
-
Metabolic barriers to cancer immunotherapy
-
Determinants of response to immunotherapy
-
What we can learn from hematologic malignancies
-
Bang on target: modulating the microbiota to improve cancer immunotherapy
-
Cellular therapies: arming immune cells
-
Other
注册费：
GROUP REGISTRATION
Groups of 3 or more participants can benefit from a registration discount. For more information, please contact us at info@cancerimmunotherapyconference.org
*Low region:Afghanistan, Burundi, Burkina Faso, Central African Republic, Congo Dem. Rep., Eritrea, Ethiopia, Guinea, Gambia, Guinea-Bissau, Liberia, Madagascar, Mali, Mozambique, Malawi, Niger, Korea, Dem. Rep., Rwanda, Sudan, Sierra Leone, Somalia, South Sudan, Syrian, Arab Republic, Chad, Togo, Uganda, Yemen Rep.
**Pre-/Postdoctoral Student: Research Scholars (including Undergraduate and PhD Students, Master graduates and Postdoctoral fellows). A formal support letter from an Institutional representative endorsing the career state is mandatory.
Cancellation policy:
Notification of cancellation must be made in writing to the Organising Secretariat. All refunds will be reimbursed only after the end of the Congress, by bank transfer, as follows:
◆ 参会对象：
科学家，临床医生，监管机构，药物开发人员和患者权益倡导者，以及其他相关卫生保健专业人士。
|
